Hangzhou Wensli Silk Culture
301066
Yoantion Industrial Inc.,
301053
Xinlei Compressor
301317
4
QIFENG
873169
5
LAISAI LASER
871263
CN Stock MarketDetailed Quotes
688314 Kontour(Xi'an) Medical Technology
- 31.40
- -0.73-2.27%
Market Closed May 9 15:00 CST
2.55BMarket Cap27.57P/E (TTM)
32.60High30.91Low30.18KlotVolume32.14Open32.13Pre Close95.55MTurnover3.71%Turnover Ratio28.86P/E (Static)81.24MShares35.5052wk High3.87P/B2.55BFloat Cap16.9752wk Low38.56Limit Up81.24MShs Float94.03Historical High25.70Limit Down5.26%Amplitude16.38Historical Low0.36Dividend TTM31.66Avg Price16.23KlotAsk1.15%Div YieldTTM100Lot Size11.71KlotBid
Kontour(Xi'an) Medical Technology Key Stats
All
YOY
| (Q3)Mar 31, 2025 | (FY)Dec 31, 2024 | (Q9)Sep 30, 2024 | (Q6)Jun 30, 2024 | (Q3)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q9)Sep 30, 2023 | (Q6)Jun 30, 2023 | (Q3)Mar 31, 2023 | (FY)Dec 31, 2022 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | ||||||||||
| Goods sale service render cash | 9.51%92.03M | 18.82%367.83M | 14.49%273.58M | 12.15%174.96M | 10.66%84.04M | 18.38%309.58M | 22.02%238.95M | 21.12%156M | 32.13%75.94M | 9.88%261.53M |
| Refunds of taxes and levies | --0 | --0 | --0 | ---- | --0 | --0 | --0 | ---- | ---- | --1.5M |
| Net deposit increase | --0 | --0 | --0 | ---- | --0 | --0 | --0 | ---- | ---- | ---- |
| Net increase in borrowings from central bank | --0 | --0 | --0 | ---- | --0 | --0 | --0 | ---- | ---- | ---- |
| Net increase in placements from other financial institutions | --0 | --0 | --0 | ---- | --0 | --0 | --0 | ---- | ---- | ---- |
| Cash received from interests, fees and commissions | --0 | --0 | --0 | ---- | --0 | --0 | --0 | ---- | ---- | ---- |
| Net increase in repurchase business capital | --0 | --0 | --0 | ---- | --0 | --0 | --0 | ---- | ---- | ---- |
| Premiums received from original insurance contracts | --0 | --0 | --0 | ---- | --0 | --0 | --0 | ---- | ---- | ---- |
| Net cash received from reinsurance business | --0 | --0 | --0 | ---- | --0 | --0 | --0 | ---- | ---- | ---- |
| Net increase in deposits from policyholders | --0 | --0 | --0 | ---- | --0 | --0 | --0 | ---- | ---- | ---- |
| Net increase in funds disbursed | --0 | --0 | --0 | ---- | --0 | --0 | --0 | ---- | ---- | ---- |
| Net cash received from trading securities | --0 | --0 | --0 | ---- | --0 | --0 | --0 | ---- | ---- | ---- |
| Cash received relating to other operating activities | 16.10%2.37M | 4.46%19.26M | 22.97%15.38M | 64.17%11.3M | -12.81%2.04M | 21.01%18.43M | -6.72%12.51M | 67.65%6.88M | 121.88%2.34M | -21.07%15.23M |
| Cash inflows from operating activities | 9.67%94.4M | 18.01%387.09M | 14.92%288.96M | 14.35%186.26M | 9.96%86.08M | 17.88%328.02M | 19.32%251.46M | 21.19%162.88M | 33.75%78.28M | 8.14%278.26M |
| Goods services cash paid | 183.36%19.63M | -14.83%45.31M | -18.40%34.76M | -38.62%17.47M | -45.03%6.93M | 53.74%53.19M | 59.83%42.59M | 37.34%28.46M | 44.03%12.6M | -8.91%34.6M |
| Staff behalf paid | 16.41%24.81M | 9.34%77.97M | 13.24%58.45M | 14.17%39.78M | 15.54%21.32M | 14.23%71.31M | 14.75%51.62M | 21.03%34.84M | 16.34%18.45M | 38.23%62.42M |
| All taxes paid | 11.31%12.25M | -1.97%53.96M | -3.95%43.59M | -17.95%26.41M | -28.51%11M | 56.36%55.05M | 101.48%45.39M | 170.69%32.18M | 137.47%15.39M | 31.20%35.21M |
| Net loan and advance increase | --0 | --0 | --0 | ---- | --0 | --0 | --0 | ---- | ---- | ---- |
| Net deposit in central bank and institutions | --0 | --0 | --0 | ---- | --0 | --0 | --0 | ---- | ---- | ---- |
| Net lend capital | --0 | --0 | --0 | ---- | --0 | --0 | --0 | ---- | ---- | ---- |
| Cash paid for fees and commissions | --0 | --0 | --0 | ---- | --0 | --0 | --0 | ---- | ---- | ---- |
| Cash paid for indemnity of original insurance contract | --0 | --0 | --0 | ---- | --0 | --0 | --0 | ---- | ---- | ---- |
| Policy dividend cash paid | --0 | --0 | --0 | ---- | --0 | --0 | --0 | ---- | ---- | ---- |
| Cash paid relating to other operating activities | 18.18%15.68M | 10.04%69.59M | -9.79%42.51M | -23.79%26.68M | -26.28%13.27M | 17.00%63.24M | 13.12%47.12M | 32.78%35.01M | 52.79%18M | 22.70%54.05M |
| Cash outflows from operating activities | 37.81%72.37M | 1.66%246.84M | -3.97%179.31M | -15.45%110.34M | -18.51%52.52M | 30.34%242.79M | 37.48%186.72M | 48.68%130.5M | 50.32%64.44M | 20.94%186.28M |
| Net cash flows from operating activities | -34.37%22.03M | 64.57%140.25M | 69.37%109.65M | 134.46%75.92M | 142.56%33.56M | -7.34%85.22M | -13.60%64.74M | -30.56%32.38M | -11.62%13.84M | -10.95%91.98M |
| Investing cash flow | ||||||||||
| Cash received from disposal of investments | --0 | --0 | --0 | ---- | --0 | --0 | --0 | ---- | ---- | ---- |
| Cash received from returns on investments | 137.66%332.72K | -32.96%2.21M | -35.62%1.36M | -24.47%834.83K | -23.94%140K | -4.44%3.29M | -6.72%2.11M | -25.35%1.11M | -29.59%184.06K | 59.71%3.45M |
| Net cash received from disposal of fix assets、 intangible assets 、other long-term asset | -99.74%1.5K | 12,392.40%661.08K | 12,430.85%661.07K | 12,543.57%660.88K | --571.83K | --5.29K | --5.28K | --5.23K | ---- | --0 |
| Net cash received from disposal of subsidiaries and other business units | --0 | --0 | --0 | ---- | --0 | --0 | --0 | ---- | ---- | ---- |
| Cash received relating to other investing activities | 224.29%227M | -19.05%665M | -37.22%345M | -37.21%200M | -46.36%70M | -0.42%821.5M | 4.47%549.5M | -11.65%318.5M | 9.66%130.5M | 90.09%825M |
| Cash inflows from investing activities | 221.49%227.33M | -19.03%667.87M | -37.09%347.02M | -36.96%201.5M | -45.89%70.71M | -0.44%824.8M | 4.42%551.62M | -11.71%319.61M | 9.58%130.68M | 89.79%828.45M |
| Cash paid to acquire fixed assets intangible assets and other long-term assets | -28.75%9.6M | 233.29%47.4M | 292.98%35.22M | 301.57%25.5M | 1,243.40%13.47M | -21.85%14.22M | -29.24%8.96M | -23.24%6.35M | -74.94%1M | -67.06%18.2M |
| Cash paid to acquire investments | 1,900.00%15M | 91.94%32.85M | 92.26%32.82M | -24.25%12.83M | -75.02%750K | 26.64%17.11M | 28.53%17.07M | 30.20%16.94M | -76.35%3M | --13.51M |
| Net cash paid to acquire subsidiaries and other business units | --0 | --10.78M | --10.78M | --9.24M | --0 | --0 | --0 | --0 | ---- | ---- |
| Impawned loan net increase | --0 | --0 | --0 | ---- | --0 | --0 | --0 | ---- | ---- | ---- |
| Cash paid relating to other investing activities | 98.71%308M | -18.66%668.2M | -37.73%420M | -43.89%255M | -34.18%155M | -0.42%821.5M | 9.32%674.5M | -2.36%454.5M | -13.89%235.5M | 90.09%825M |
| Cash outflows from investing activities | 96.55%332.6M | -10.98%759.22M | -28.79%498.82M | -36.67%302.57M | -29.35%169.22M | -0.45%852.84M | 8.96%700.53M | -1.85%477.79M | -17.47%239.51M | 75.11%856.71M |
| Net cash flows from investing activities | -6.86%-105.26M | -225.83%-91.36M | -1.93%-151.8M | 36.10%-101.07M | 9.48%-98.51M | 0.81%-28.04M | -29.85%-148.92M | -26.74%-158.18M | 36.34%-108.82M | 46.40%-28.27M |
| Financing cash flow | ||||||||||
| Cash received from capital contributions | --0 | --0 | --0 | ---- | --0 | --0 | --0 | ---- | ---- | ---- |
| -Including: Cash received from capital contributions by minority shareholders of subsidiaries | --0 | --0 | --0 | ---- | --0 | --0 | --0 | ---- | ---- | ---- |
| Cash from borrowing | --0 | --0 | --0 | ---- | --0 | --0 | --0 | ---- | ---- | 275.52%15.01M |
| Cash received relating to other financing activities | --0 | --0 | --0 | --0 | -95.64%108.95K | --2.5M | --2.5M | --2.5M | --2.5M | --0 |
| Cash inflows from financing activities | --0 | --0 | --0 | --0 | -95.64%108.95K | -83.35%2.5M | -83.05%2.5M | -82.70%2.5M | -82.27%2.5M | -93.43%15.01M |
| Borrowing repayment | --0 | --0 | --0 | ---- | --50.1K | --0 | --0 | ---- | ---- | ---- |
| Dividend interest payment | -0.77%465.02K | 34.16%42.7M | -12.16%27.56M | -12.61%27.01M | 66.50%468.62K | -13.74%31.82M | -14.35%31.37M | -15.00%30.91M | 107.64%281.46K | 20.38%36.9M |
| -Including:Cash payments for dividends or profit to minority shareholders | --0 | --0 | --0 | ---- | --0 | --0 | --0 | ---- | ---- | ---- |
| Cash payments relating to other financing activities | 9.77%652.27K | 31.59%3.25M | 35.82%2.39M | 57.04%1.82M | 7.64%594.21K | -87.37%2.47M | -88.47%1.76M | -92.23%1.16M | 14.75%552.02K | 26.41%19.55M |
| Cash outflows from financing activities | 0.39%1.12M | 33.97%45.95M | -9.62%29.94M | -10.09%28.83M | 33.53%1.11M | -39.24%34.29M | -36.13%33.13M | -37.47%32.07M | 35.17%833.47K | 22.40%56.44M |
| Net cash flows from financing activities | -11.29%-1.12M | -44.51%-45.95M | 2.24%-29.94M | 2.49%-28.83M | -160.24%-1M | 23.26%-31.79M | 17.48%-30.63M | 19.73%-29.57M | -87.64%1.67M | -122.70%-41.43M |
| Net cash flow | ||||||||||
| Exchange rate change effecting cash and cash equivalents | 130.75%73.57K | -167.79%-329.52K | -203.21%-628.13K | -165.42%-380.51K | -11.98%-239.29K | -70.25%486.08K | -72.21%608.59K | -52.89%581.61K | -115.32%-213.69K | 423.08%1.63M |
| Net increase in cash and cash equivalents | -27.34%-84.28M | -89.86%2.62M | 36.33%-72.71M | 64.87%-54.37M | 29.24%-66.19M | 8.24%25.88M | -52.91%-114.19M | -36.05%-154.79M | 34.08%-93.53M | -89.72%23.91M |
| Add:Begin period cash and cash equivalents | 0.70%377.74M | 7.41%375.12M | 7.41%375.12M | 7.41%375.12M | 7.41%375.12M | 7.35%349.24M | 7.35%349.24M | 7.35%349.24M | 7.35%349.24M | 250.57%325.33M |
| End period cash equivalent | -5.01%293.47M | 0.70%377.74M | 28.66%302.41M | 64.95%320.75M | 20.81%308.93M | 7.41%375.12M | -6.23%235.05M | -8.09%194.45M | 39.40%255.71M | 7.35%349.24M |
| Currency Unit | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY |
| Accounting Standards | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) |
| Audit Opinions | -- | -- | -- | -- | -- | Unqualified opinion | -- | -- | -- | Unqualified opinion |
| Auditor | -- | -- | -- | -- | -- | China Audit Zhonghuan Certified Public Accountants Co., Ltd. (Special General Partnership) | -- | -- | -- | China Audit Zhonghuan Certified Public Accountants Co., Ltd. (Special General Partnership) |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.